Saturday, October 3, 2026

USD/EUR Bullish Momentum: 0.82% Up In The Last 5 Sessions

USD/EUR Bullish Momentum: 0.82% Up In The Last 5 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.82% for the last 5 sessions. At 17:07 EST on Thursday, 29 June, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 2.075% up from its 52-week low and 12.221% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.28%, a negative 0.09%, and a positive 0.35%, respectively.

USD/EUR's highest amplitude of average volatility was 0.30% (last week), 0.35% (last month), and 0.35% (last quarter), respectively.

News about

  • Usd/jpy trades with modest intraday losses, below 144.00 amid intervention fears. According to FXStreet on Wednesday, 28 June, "This further benefits the JPY's relative safe-haven status and contributes to the offered tone around the USD/JPY pair. ", "The USD/JPY pair comes under some selling pressure during the Asian session on Wednesday and erodes a part of the previous day's gains to levels beyond the 144.00 mark, or a fresh high since November 2022. "
  • Usd/jpy price analysis: rising wedge, Japan intervention fears prod yen pair buyers at 144.00. According to FXStreet on Wednesday, 28 June, "With this, the USD/JPY sellers remain hopeful of consolidating the biggest monthly gains since February.", "Even so, the 100-Hour Moving Average (HMA) and the one-week-old rising support line, respectively near 143.30 and 142.80 act as additional downside filters to challenge the USD/JPY bears."
  • Usd/jpy consolidates near YTD high in US upbeat data, fed’s powell and boj’s ueda eyed. According to FXStreet on Tuesday, 27 June, "After the data release, the USD/JPY extended its gains past the 144.00 mark, underpinned by the US 10-year Treasury Note, sitting at 3.772%, advanced four basis points.", "But recently, dovish comments by the Bank of Japan's (BoJ) officials aimed to keep their ultra-loose monetary policy stance, alongside an empty Japanese economic docket, suggests further USD/JPY upside is expected."
  • According to FXStreet on Tuesday, 27 June, "The Japanese Yen seems to have found some support from the above comments, as USD/JPY holds lower ground near 140.35, losing 0.10% on the day."
  • Usd/jpy: yen bulls May need to be patient – OCBC. According to FXStreet on Tuesday, 27 June, "Such activities will only serve to slow the pace of USD/JPY upticks especially if the uptrend remains intact. ", "Looking out, we expect USD/JPY to trade lower on the back of a moderate-to-soft USD profile (as Fed tightening stretches into late cycle and that USD can fall when pause or pivot comes into play) and expectation for BoJ to shift towards policy normalisation amid higher inflationary pressures in Japan."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com